Inhibition of tumor growth by radiofrequency therapy

Plain English Summary

Summary written for general audiences

Japanese researchers tested radiofrequency therapy at 13.56 MHz on experimental tumors in rats, finding that targeted heating to 40-46°C caused tumor regression in some cases. The RF energy raised tumor temperatures 5-10°C above surrounding tissue, with complete tumor regression achieved in 7 of 23 rats during longer treatments.

Why This Matters

This 1979 study represents early research into radiofrequency hyperthermia for cancer treatment, using 13.56 MHz frequency that falls within the industrial, scientific and medical (ISM) band. What makes this particularly relevant to EMF health discussions is the frequency used - 13.56 MHz sits in the shortwave radio spectrum, far below cell phone frequencies but still within the radiofrequency range that surrounds us daily through various wireless technologies and industrial applications. The research demonstrates that RF energy can produce measurable biological effects through thermal mechanisms, heating tissue to therapeutic levels. While this was intentional medical treatment rather than environmental exposure, it illustrates how radiofrequency energy interacts with biological tissue in measurable ways. The study's finding that even brief 10-minute exposures could occasionally increase tumor growth highlights the complex relationship between RF exposure duration, intensity, and biological response.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study

Kenji TAZAWA, Ryoichi ABE, Jyuichi SAITO, Takashi SHINDO, Toshio FUJITA, Hiroshi ITO, Masao FUJINAKI (1979). Inhibition of tumor growth by radiofrequency therapy.

Show BibTeX

@article{inhibition_of_tumor_growth_by_radiofrequency_therapy_g5035,
  author = {Kenji TAZAWA and Ryoichi ABE and Jyuichi SAITO and Takashi SHINDO and Toshio FUJITA and Hiroshi ITO and Masao FUJINAKI},
  title = {Inhibition of tumor growth by radiofrequency therapy},
  year = {1979},
  
  
}

Quick Questions About This Study

Yes, researchers found that 13.56 MHz RF energy could selectively heat tumors 5-10°C above surrounding tissue temperature, reaching therapeutic levels of 40-46°C for targeted treatment effects.

Complete tumor regression occurred in 7 out of 23 rats (about 30%) when treated with RF heating at 40-46°C for 30-90 minutes, showing significant therapeutic potential.

Brief 10-minute RF treatments at 40-46°C occasionally caused increased tumor growth rather than regression, suggesting treatment duration significantly affects biological outcomes with radiofrequency exposure.

The RF generator produced over 3000 watts output at the crystal-controlled frequency of 13.56 MHz, transmitted through an impedance matching circuit for efficient energy delivery.

Yes, RF therapy at 13.56 MHz produced tissue necrosis and substantial regression in experimental tumors when applied at therapeutic heating levels of 40-46°C for appropriate durations.